loading page

Therapeutic potential of amitriptyline for paraquat-induced pulmonary fibrosis: involvement of caveolin-1-mediated anti-epithelial-mesenchymal transition and inhibition of apoptosis
  • +1
  • jianshi chen,
  • xiangdong jian,
  • chunmei li,
  • bihuang cheng
jianshi chen
The Second Affiliated Hospital and Yuying Childern,s Hospital of Wenzhou Medical University

Corresponding Author:[email protected]

Author Profile
xiangdong jian
Shandong University Qilu Hospital
Author Profile
chunmei li
The Second Affiliated Hospital and Yuying Childern,s Hospital of Wenzhou Medical University
Author Profile
bihuang cheng
The Second Affiliated Hospital and Yuying Childern,s Hospital of Wenzhou Medical University
Author Profile

Abstract

The present study was performed to investigate the anti-fibrotic effect of Amitriptyline (AMT) on paraquat (PQ)-induced pulmonary fibrosis and its possible mechanism. A total of 32 C57BL/6 mice were randomly divided into control, PQ, PQ + AMT and AMT groups. Lung histopathology, blood gas analysis, hydroxyproline (HYP), TGF-β1 and IL-17 were measured. E-cadherin, N-cadherin, α-SMA and caveolin-1 were studied by immunohistochemistry and Western-blot analysis in mice and A549 cells. As we found that, compared with the PQ group, the PQ + AMT group displayed mild pathological changes in pulmonary fibrosis, lower HYP, IL-17 and TGF- β1 levels in lung, and levels of N-cadherin and α-SMA in the lungs were significantly decreased, but caveolin-1 was increased (p < 0.01). While SaO2 and PaO2 levels were higher. Compared with the PQ group, the apoptosis rate, N-cadherin and α-SMA levels in the A549 cells were significantly decreased after PQ treatment and high-dose AMT intervention (p < 0.01). The expressions of E-cadherin, N-cadherin and -SMA in the PQ-induced cells transfected with caveolin-1 siRNA or siControl RNA were significantly different (p < 0.01). Our results suggested that AMT inhibits PQ-induced EMT in A549 cells and improves lung histopathology and oxygenation in mice by up-regulating caveolin-1.